top of page

Zambon launches Xadago in UK for patients with mid- to late-stage Parkinson’s Disease

Andrew Lees, MD FRCP, FMedSci, Professor of Neurology, (The National Hospital for Neurology and Neurosurgery, Queen Square and Emeritus Director, Reta Lila, Weston Institute of Neurological Studies, University College London, Institute of Neurology) said: "After 10 years with no new drugs for Parkinson's disease I welcome the addition of another effective treatment option for patients".

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page